Michael Arougheti is Co-Founder, Chief Executive Officer and Director of Ares Management Corporation, a leading global alternative investment manager. Prior to joining Ares in 2004, Mr. Arougheti was a Managing Partner of the Principal Finance Group of RBC Capital Partners. He previously held roles at Indosuez Capital and Kidder, Peabody & Co. Mr. Arougheti serves as the Chair of the Ares Charitable Foundation Board of Directors and is on the Governing Board of Directors of Operation HOPE. He is also a member of the Leadership Council for PATH, an international nonprofit global health organization. Mr. Arougheti is a co-owner of Major League Baseball’s Baltimore Orioles. He received a B.A. in Ethics, Politics and Economics, cum laude, from Yale University.

Michael Buckley is a Portfolio Manager and Managing Director at Duquesne Family Office. He invests primarily in public and private equities while overseeing a team of analysts. Prior to joining Duquesne in 2015, Michael was an Associate at the investment firms CPMG and Bain Capital. Michael graduated from Harvard with a degree in Applied Mathematics, summa cum laude and Phi Beta Kappa.

Before founding Maverick Silicon in 2024, Andrew C. Homan led Maverick Capital’s investments across the semiconductor, hardware, and software industries. Mr. Homan also serves as the Chairman of Maverick’s Growth Committee, as well as on the external boards of Coherent Global, SiMa Technologies, and TensorWave. Prior to joining Maverick in 2004, Mr. Homan was an Analyst in the Investment Banking Division, Financial Institutions Group at Goldman Sachs. Mr. Homan received his B.A. in Economics from Yale University, where he was a member of the heavyweight crew team.

Paul Tudor Jones II is founder, Co-Chairman, CIO, and the controlling principal of Tudor Investment Corporation, engaged in trading across global fixed income, equity, currency and commodity markets for an international client base. His current philanthropic service includes among many others, Robin Hood, JUST Capital Foundation, The Everglades Foundation, African Community & Conservation Foundation, and the Advisory Board of the University of Virginia’s Contemplative Sciences Center. Jones holds a B.A. in Economics from the University of Virginia and was awarded an honorary doctorate from the University of Glasgow. He and his wife, Sonia, have four adult children. 

Doug Ostrover is Co-CEO of Blue Owl Capital, Chairman of its Board, and a member of the firm’s Executive Committee. He also serves as CEO and Co-CIO of Blue Owl Credit Advisers. Previously, Doug co-founded Owl Rock Capital Partners, the predecessor firm to Blue Owl’s credit platform.

Prior to co-founding Owl Rock, Doug was a founder of GSO Capital Partners, Blackstone’s alternative credit platform, in 2005. Prior to GSO, Doug was Chairman and Global Co-Head of Credit Suisse First Boston’s Leveraged Finance Group, and Managing Director at Donaldson, Lufkin & Jenrette.

Doug serves on the boards of the Michael J. Fox Foundation and the Mt. Sinai Health System, is on the Leadership Council for Memorial Sloan Kettering, and is on the investment committee of the Brunswick School.

He holds an MBA from NYU’s Stern School of Business and a B.A. in Economics from the University of Pennsylvania.

Larry Robbins is the CEO of Glenview Capital. Glenview drives performance through deep fundamental research and a long-term orientation with a philosophy to think and act like owners. Prior to founding Glenview, Larry spent six years as an analyst and partner at Omega Advisors on their US equity long/short team and began his career at Gleacher & Company, a merger and advisory boutique in New York.

Larry graduated with honors from the Wharton School and Moore School of the University of Pennsylvania in 1992, where he received his Bachelor of Science in Economics and Engineering, with majors in accounting, finance, marketing, and systems engineering. Larry became a Certified Public Accountant in 1991 in his then home state of Illinois.

Through their Robbins Family Foundation, Larry and his wife, Sarahmay, are active supporters of education reform both in New York City and on the national level. Larry serves as Chairman of the Board of Array Education and as a Board Member of KIPP New York, Zearn, and Relay Graduate School of Education.

Aaron Weiner is the Founder and CIO of Atlantic Wolf Capital, a New York-based alternative investment firm specializing in strategies in the healthcare and technology sectors to deliver superior risk-adjusted returns.

Prior to founding AWC, Mr. Weiner was a Partner and Managing Director at Coatue Management, where he served as Head of Healthcare. In 2022, he founded Coatue’s Tactical Solutions business with a $3 billion inaugural fund focused on structured capital solutions.

Prior to joining Coatue, Mr. Weiner held roles in Blackstone’s private equity business and Goldman Sachs & Co.’s healthcare investment banking group.

Mr. Weiner graduated magna cum laude from Cornell University with a B.S. in Applied Economics and Management. . He serves on the Leadership Council of Robin Hood, New York City’s largest poverty-fighting organization

Lauren Taylor Wolfe is Co-Founder and Managing Partner of Impactive Capital, a $3 billion active impact investing firm. Impactive Capital helps companies allocate capital effectively and ethically to drive lasting sustainable, profitable, and valuable businesses. Before founding Impactive Capital, Lauren was a Managing Director at Blue Harbour Group, where she led investments in the technology, consumer, business, and healthcare services industries. Prior to that, she was a Portfolio Manager at SIAR Capital, where she invested in small capitalization public companies and private companies.

Lauren received an MBA from The Wharton School at University of Pennsylvania and a B.S. Magna Cum Laude from Cornell University. Lauren has served on several boards including those of Envestnet Inc and HD Supply, is on the Steering Committee of 30% Club, and is an Angel Member of 100 Women in Finance.

Josh Wolfe co-founded Lux Capital to support scientists and entrepreneurs who pursuealternative solutions to complex problems that can lead us into a brighter future. Josh is a Director at Aera Therapeutics, Cajal Neuroscience, Eikon Therapeutics, Impulse Labs, Kallyope, Osmo, and Variant Bio, and helped lead Lux Capital’s investments in Anduril, Echodyne, Planet, Hadrian, Osmo, and Resilience. He serves on the board of and is a founding investor in Kymeta, making cutting-edge antennas for high-speed global satellite and space communications. In 2008, Josh co-founded and funded Kurion, a nuclear waste clean up business using advanced robotics and state-of-the-art engineering and chemistry, which was later acquired for nearly $400 million. He previously held roles at Salomon Smith Barney and Merrill Lynch.

Josh is a columnist and editor with Forbes has advised on nanotechnology and emerging technologies at The White House and Capital Hill; is a lecturer at MIT, Harvard, Yale, Cornell, Columbia and NYU; and is a Westinghouse semi-finalist. He is a term member at The Council on Foreign Relations, a Trustee at the Santa Fe Institute, and Chairman of Coney Island Prep charter school. Josh grew up in Brooklyn and graduated from Cornell University with a B.S. in Economics and Finance.